Research Progress on the Mechanism of Baicalein in Scutellaria Baicalensis Against Liver Fibrosis

Baicalein is a flavonoid extracted from the dried root of Scutellaria baicalensis, family Labiatae, which can inhibit hepatic stellate cell activation, collagen deposition, reduce the release of inflammatory factors, and regulate the cell cycle and apoptosis, thereby controlling the balance between synthesis and catabolism of hepatic extracellular matrix. In this paper, we reviewed the literature on baicalein in the treatment of hepatic fibrosis in recent years and found that baicalein inhibits inflammatory factors such as interleukin and tumor necrosis factor, and regulates the signaling pathways such as transforming growth factor-β, Wnt/β-catenin, nuclear factor-kB, PDGF, MAPK and other related signaling pathways, and then influences the activation of hepatic stellate cells, extracellular matrix deposition, and inhibits the progression of hepatic fibrosis. The aim of this paper is to provide new ideas and a theoretical basis for the treatment of liver fibrosis and the development of new drugs.

Authors

Institutions

Publication Details

Journal
Journal of Contemporary Medical Practice
Published
2025-04-29
DOI
https://doi.org/10.53469/jcmp.2025.07(04).01
Citations
1
Primary Topic
Flavonoids in Medical Research
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Research Progress on the Mechanism of Baicalein in Scutellaria Baicalensis Against Liver Fibrosis

Guotai Wang, Chenyang Wu
1 citations
Journal of Contemporary Medical Practice
Flavonoids in Medical Research
1.39
article

Research Progress on the Mechanism of Baicalein in Scutellaria Baicalensis Against Liver Fibrosis

Guotai Wang, Chenyang Wu
article en
1 citations

Abstract

Baicalein is a flavonoid extracted from the dried root of Scutellaria baicalensis, family Labiatae, which can inhibit hepatic stellate cell activation, collagen deposition, reduce the release of inflammatory factors, and regulate the cell cycle and apoptosis, thereby controlling the balance between synthesis and catabolism of hepatic extracellular matrix. In this paper, we reviewed the literature on baicalein in the treatment of hepatic fibrosis in recent years and found that baicalein inhibits inflammatory factors such as interleukin and tumor necrosis factor, and regulates the signaling pathways such as transforming growth factor-β, Wnt/β-catenin, nuclear factor-kB, PDGF, MAPK and other related signaling pathways, and then influences the activation of hepatic stellate cells, extracellular matrix deposition, and inhibits the progression of hepatic fibrosis. The aim of this paper is to provide new ideas and a theoretical basis for the treatment of liver fibrosis and the development of new drugs.

Journal of Contemporary Medical PracticeVol. 7(4)
Affiliated Hospital of Shaanxi University of Chinese Medicine (CN), Shaanxi University of Chinese Medicine (CN)
Openalex Percentile: Top 21%
Flavonoids in Medical Research
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Research Progress on the Mechanism of Baicalein in Scutellaria Baicalensis Against Liver Fibrosis — Guotai Wang, Chenyang Wu · Journal of Contemporary Medical Practice (2025) | TGRS Research Map | TGRS